Joe Pitts

Could legislation that applies different standards adversely affect the quality of drugs made available to patients?

Hasn't the FDA recently used its manufacturing inspection authority to inspect manufacturers acting under the guise of compounding recently?

I think it is irresponsible for us to stand by and expect FDA to cobble together a piecemeal approach to regulating the practice of compounding pharmacy.

What are some of the lessons the agency has learned during the period of this outbreak?

I commend my colleague Mr. Pallone for his wise counsel and leadership.

And finally, would a National track-and-trace standard increase the efficacy of product recalls?

Will national uniformity increase the security of the supply chain and improve patient safety?

We need to better safeguard our Nation's drug supply but we need to make sure whatever legislation we enact actually achieves that goal, it doesn't just give people the hope that someday we will achieve it.

So finally, would a national track-and-trace standard increase the efficiency of product recalls?

Will data exchange and systems between participants in the supply chain increase the security of our drug supply and improve patient safety? Please explain.

Will product serialization increase the security of the supply chain and improve patient safety? Please explain with your answer.

Is it important to preserve the States' ability to license and enforce national standards?

There is no real Democratic or Republican way of protecting the American public.

I urge the subcommittee to make sure we get this proposal right and that we work together to get there.

Members of this Subcommittee have been interested in securing our Nation's pharmaceutical supply chain for many years.

I think there are a number of very important provisions in the law that will make coverage more affordable for small businesses.

My constituents are looking for full-time jobs but the ACA is making those jobs harder to come by.

I also hear from constituents who are being hurt by the ACA two or three times a week.

The President promised that the ACA would help to make health insurance cheaper for the American people, but unfortunately, exactly the opposite is happening.

I would be remiss, though, if I didn't mention the need to fully implement mental health parity.

I appreciate the President's leadership on this and am pleased that his budget reflects these priorities.

I am also pleased to see a strong investment in biomedical and behavioral research at the NIH.

I appreciate the Administration's continuing commitment to public health.

I hope I have your commitment to closely monitor and evaluate these dual demonstrations to assure protection of our vulnerable seniors and people with disabilities.

I am concerned about some of the proposals in the President's budget such as raising costs on Medicare beneficiaries.